PriceScrib / Switzerland

BAG snapshot · 3 November 2026 · CHF

PriceScrib. Swiss medicine list prices.

Limited preview: 30 published packs across ten Swiss authorisation holders, selected from the largest SL portfolios by listed pack count. Sample results are not representative of the full market or sales share.

Sample packs

30

Products

17

Companies

10

Sample median price

CHF 191.05

Product-level prices

Product / active ingredientForm & packAuthorisation holderPublic CHF incl. VATLast factory-price change

Abacavir Lamivudin Sandoz

Abacavirum, Lamivudinum

J05AR02

Filmtabl 600/300mg

Blist 30 Stk

Sandoz Pharmaceuticals AGCHF 268.952025-12-01

Abirateron Accord

Abirateroni acetas

L02BX03 · Reimbursement limitation · Price model

Filmtabl 500 mg

Blist 56 Stk

Accord Healthcare AGCHF 992.052022-04-01

Abirateron Sandoz

Abirateroni acetas

L02BX03 · Reimbursement limitation · Price model

Filmtabl 1000 mg

Blist 28 Stk

Sandoz Pharmaceuticals AGCHF 992.852022-10-01

Abirateron Sandoz

Abirateroni acetas

L02BX03 · Reimbursement limitation · Price model

Filmtabl 500 mg

Blist 56 Stk

Sandoz Pharmaceuticals AGCHF 992.052022-01-01

Abirateron Spirig HC

Abirateroni acetas

L02BX03 · Reimbursement limitation · Price model

Filmtabl 500 mg

Blist 56 Stk

Spirig HealthCare AGCHF 992.052022-01-01

Showing 5 of 30 matching sample packs.

Your pricing analytics dashboard

Click here to request your plug-and-play pricing analytics dashboard

Source & interpretation

Official Federal Office of Public Health (BAG/OFSP) Specialities List, published 3 November 2026. This is a fixed snapshot, not live pricing; no price-history trend is inferred. Prices are per specified pack, not per dose or treatment. Products, strengths and pack sizes may not be comparable. Actual net prices, rebates, reimbursement conditions and patient costs can differ.

Only SL entries are included; GGSL and GGML entries are excluded. “Company” means the Swiss authorisation holder as published, not a consolidated global group. Missing prices are excluded from medians. This is market information, not medical or prescribing advice.